COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1492.0 | 8 | 0015-0107 | 399.16 | 107.89 | 351 | 69.60 | 0.911 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 262.7 | 8 | 0016-0116 | 77.68 | 116.31 | 300 | 65.60 | 0.876 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 278.9 | 8 | 0017-0119 | 94.58 | 118.73 | 270 | 66.18 | 0.775 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 262.2 | 8 | 0018-0117 | 144.91 | 118.43 | 327 | 67.94 | 0.890 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 378.3 | 8 | 0019-0126 | 297.21 | 126.26 | 313 | 66.77 | 0.882 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 550.5 | 8 | 0020-0127 | 571.17 | 127.19 | 260 | 64.67 | 0.781 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 320.6 | 8 | 0021-0132 | 461.59 | 131.56 | 320 | 67.60 | 0.880 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 4172.2 | 8 | 0022-0137 | 524.65 | 137.50 | 266 | 61.46 | 0.885 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 288.0 | 8 | 0023-0143 | 182.96 | 143.82 | 360 | 72.18 | 0.868 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 311.1 | 8 | 0024-0144 | 858.72 | 143.84 | 286 | 62.53 | 0.919 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 228.1 | 8 | 0025-0148 | 116.34 | 148.61 | 341 | 68.77 | 0.906 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1632.0 | 8 | 0026-0148 | 631.03 | 147.91 | 212 | 54.53 | 0.896 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 314.3 | 8 | 0027-0163 | 384.92 | 163.20 | 349 | 70.18 | 0.890 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 306.1 | 8 | 0028-0162 | 498.33 | 161.44 | 241 | 60.77 | 0.820 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 283.3 | 8 | 0029-0179 | 255.75 | 179.69 | 303 | 66.18 | 0.869 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 598.9 | 8 | 0030-0193 | 903.86 | 192.59 | 363 | 77.60 | 0.758 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 252.7 | 8 | 0031-0192 | 128.31 | 192.14 | 319 | 68.77 | 0.848 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 325.7 | 8 | 0032-0198 | 834.68 | 198.26 | 273 | 61.36 | 0.911 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 451.7 | 8 | 0033-0199 | 509.73 | 199.88 | 314 | 73.60 | 0.728 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 263.6 | 8 | 0034-0200 | 934.39 | 200.06 | 339 | 68.77 | 0.901 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 311.1 | 8 | 0035-0203 | 451.50 | 203.05 | 309 | 66.77 | 0.871 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 369.2 | 8 | 0036-0212 | 809.27 | 211.52 | 260 | 59.94 | 0.909 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1009.0 | 8 | 0037-0212 | 298.17 | 211.31 | 305 | 67.36 | 0.845 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1187.4 | 8 | 0038-0219 | 171.70 | 218.50 | 349 | 70.18 | 0.890 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 353.9 | 8 | 0039-0233 | 637.45 | 233.56 | 392 | 80.67 | 0.757 |